Distinctive psychological and social experiences of women choosing prophylactic oophorectomy for cancer prevention

References

• Bonadies, D. C., Moyer, A., & Matloff, E. T. (2011). What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy. Familial Cancer, 10(1), 79–85.
   PubMed Web of Science ®Google Scholar
• den Heijer, M., Vos, J., Seynaeve, C., Vanheusden, K., Duivenvoorden, H. J., Tilanus-Linthorst, M., … Tibben, A. (2012). The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer. Psycho-Oncology, 21(2), 153–160.
   PubMed Web of Science ®Google Scholar
• Elwyn, G., Frosch, D., Thomson, R., Joseph-Williams, N., Lloyd, A., Kinnersley, P., … Barry, M. (2012). Shared decision making: A model for clinical practice. Journal of General Internal Medicine, 27(10), 1361–1367.
   PubMed Web of Science ®Google Scholar
• Etchegary, H., Miller, F., Delaat, S., Wilson, B., Carroll, J., & Cappelli, M. (2009). Decision-making about inherited cancer risk: Exploring dimensions of genetic responsibility. Journal of Genetic Counseling, 18(3), 252–264.
   PubMed Web of Science ®Google Scholar
• Finch, A. P., Lubinski, J., Møller, P., Singer, C. F., Karlan, B., … Narod, S. A. (2014). Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol, 32(15), 1547–1553.
   PubMed Web of Science ®Google Scholar
• Finch, A., & Narod, S. A. (2011). Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review. Maturitas, 70(3), 261–265.
   PubMed Web of Science ®Google Scholar
• Giles, K. (2015). Decision aids for people facing health treatment or screening decisions. International Journal of Evidence-Based Healthcare, 13(2), 112–113.
   PubMed Web of Science ®Google Scholar
• Giorgi, A. (1997). The theory, practice and evaluation of the phenomenological method as a qualitative research procedure. Journal of Phenomenological Psychology, 28(2), 235–260.
   Google Scholar
• Graeser, M. K., Engel, C., Rhiem, K., Gadzicki, D., Bick, U., Kast, K., … Schmutzler, R. K. (2009). Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology, 27(35), 5887–5892.
   PubMed Web of Science ®Google Scholar
• Guest, G., & MacQueen, K. M. (2008). Handbook for team-based qualitative research. Walnut Creek, CA: AltaMira Press.
   Google Scholar
• Hallowell, N., Baylock, B., Heiniger, L., Butow, P. N., Patel, D., Meiser, B., … Price, M. A. (2012). Looking different, feeling different: Women's reactions to risk-reducing breast and ovarian surgery. Familial Cancer, 11(2), 215–224.
   PubMed Web of Science ®Google Scholar
• Hallowell, N., Jacobs, I., Richards, M., Mackay, J., & Gore, M. (2001). Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy. Journal of Medical Genetics, 38, 683–691.
   PubMed Web of Science ®Google Scholar
• Hampel, H., Sweet, K., Westman, J. A., Offit, K., & Eng, C. (2004). Referral for cancer genetics consultation: A review and compilation of risk assessment criteria. Journal of Medical Genetics, 41(2), 81–91.
   PubMed Web of Science ®Google Scholar
• Howard, A. F., Balneaves, L. G., Bottorff, J. L., & Rodney, P. (2011). Preserving the self: The process of decision making about hereditary breast cancer and ovarian cancer risk reduction. Qualitative Health Research, 21(4), 502–519.
   PubMed Web of Science ®Google Scholar
• Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., … Skates, S. J. (2016). Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet, 387(10022), 945–956.
   PubMed Web of Science ®Google Scholar
• Jeffers, L., Morrison, P. J., McCaughan, E., & Fitzsimons, D. (2014). Maximising survival: The main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2. European Journal of Oncology Nursing, 18(4), 411–418.
   PubMed Web of Science ®Google Scholar
• Johansen, N., Liavaag, A. H., Tanbo, T. G., Dahl, A. A., Pripp, A. H., & Michelsen, T. M. (2016). Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy. Gynecologic Oncology, 140(1), 101–106.
   PubMed Web of Science ®Google Scholar
• Joseph-Williams, N., Elwyn, G., & Edwards, A. (2014). Knowledge is not power for patients: A systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Education and Counseling, 94(3), 291–309.
   PubMed Web of Science ®Google Scholar
• Larkin, M., Watts, S., & Clifton, E. (2006). Giving voice and making sense in interpretative phenomenological analysis. Qualitative Research in Psychology, 3(2), 102–120.
   Google Scholar
• Maeland, M. K., Eriksen, E. O., & Synnes, O. (2014). The loss of a mother and dealing with genetic cancer risk: Women who have undergone prophylactic removal of the ovaries. European Journal of Oncology Nursing, 18(5), 521–526.
   PubMed Web of Science ®Google Scholar
• Metcalfe, K. A., Birenbaum-Carmeli, D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., … Narod, S. A., Hereditary Breast Cancer Clinical Study Group. (2008). International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer, 122(9), 2017–2022.
   PubMed Web of Science ®Google Scholar
• Moldovan, R., Keating, S., & Clancy, T. (2015). The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. Familial Cancer, 14(1), 51–60.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. (2016). NCCN Guidelines Version 1.2017 Genetic/Familial High-Risk Assessment: Breast and Ovarian.
   Google Scholar
• National Institute for Health and Care Excellence [NICE]. (2013). Familial breast cancer: Classification, care and managing breast cancer and related risks in people with a family history of breast cancer. NICE Guideline (CG164).
   Google Scholar
• Paluch-Shimon, S., Cardoso, F., Sessa, C., Balmana, J., Cardoso, M. J., Gilbert, F., & Senkus, E., ESMO Guidelines Committee. (2016). Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann Oncol, 27(suppl 5), v103–v110.
   PubMedGoogle Scholar
• Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 66(1), 7–30.
   PubMed Web of Science ®Google Scholar
• Smith, J. A., & Osborn, M. (2015). ‘Interpretative phenomenological analysis’. In J. A. Smith Qualitative psychology: A practical guide to research methods (ed.) 3rd edn. London:SAGE. Pgs 25–52.
   Google Scholar
• Smith, J. A., Flowers, P., & Larkin, M. (2009). Interpretative phenomenological analysis: Theory and research. London: Sage.
   Google Scholar
• van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., Oosterwijk, J. C., Hoogerbrugge, N., … van Daal, W. A. (2004). Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology, 22(16), 3293–3301.
   PubMed Web of Science ®Google Scholar
• Wierman, M. E., Nappi, R. E., Avis, N., Davis, S. R., Labrie, F., Rosner, W., & Shifren, J. L. (2010). Endocrine aspects of women's sexual function. Journal of Sexual Medicine, 7(1Pt 2), 561–585.
   PubMedGoogle Scholar